Clinical trials
Completed Phase 1/2 COVID-19 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 68 |
| 2021 | 41 |
| 2022 | 12 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 128 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioNTech SE | 4 |
| AnGes, Inc. | 3 |
| Cellid Co., Ltd. | 2 |
| Entos Pharmaceuticals Inc. | 2 |
| Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2 |
| Immune Biosolutions Inc | 2 |
| Institute of Medical Biology, Chinese Academy of Medical Sciences | 2 |
| Joakim Dillner | 2 |
| Novavax | 2 |
| R-Pharm | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 128 |
| Coronavirus Infections | 21 |
| Respiratory Distress Syndrome | 13 |
| Severe Acute Respiratory Syndrome | 9 |
| Pneumonia | 6 |
| Pneumonia, Viral | 5 |
| Virus Diseases | 5 |
| Acute Lung Injury | 3 |
| Hypoxia | 3 |
| Influenza, Human | 3 |
Trials
Showing 1 to 25 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.